BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19395969)

  • 1. Injectable immunotherapy: recommendations for safe allergen vial preparation in the office setting.
    Lay PC
    Curr Opin Otolaryngol Head Neck Surg; 2009 Jun; 17(3):223-5. PubMed ID: 19395969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of allergy vial contamination: comparison of mixing in-office versus under ventilation hood.
    Lay PC; Bass R; Hughes LF; Lin SY
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):364-6. PubMed ID: 18722213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergen vial mixing and immunotherapy: Risks of infections and vial contamination.
    Lay PC; Bass R; Lin SY
    Otolaryngol Head Neck Surg; 2007 Aug; 137(2):243-5. PubMed ID: 17666249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15 years of allergen immunotherapy vial sterility testing.
    Hernandez CL; Waibel KH; Kosisky SE; Nelson MR; Banks TA
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):374-375. PubMed ID: 28109834
    [No Abstract]   [Full Text] [Related]  

  • 7. [Allergen-specific immunotherapy (hyposensitization). Part 1. Basics and subcutaneous application].
    Klimek L
    HNO; 2000 Jan; 48(1):59-67. PubMed ID: 10663053
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)].
    Grevers G
    MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815
    [No Abstract]   [Full Text] [Related]  

  • 9. The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist.
    Lin SY; Houser SM; Rodriguez HP
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1017-1018. PubMed ID: 17547999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How great is the value of oral hyposensitization in skin test assessed allergy in comparison with parenteral treatment?].
    Luger T
    Internist (Berl); 1996 May; 37(5):519-20. PubMed ID: 9011553
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):511-512. PubMed ID: 28259390
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and its persistence, in children and adults.
    Di Rienzo V
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
    [No Abstract]   [Full Text] [Related]  

  • 13. The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist.
    Lin SY; Houser SM; Rodriguez HP
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4):658-9. PubMed ID: 17418269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy extract treatment set preparation: making a safer and higher quality product for patients.
    Nelson MR; Petersen MM; Wolverton WO; Mikita CP
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):399-405. PubMed ID: 23881510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparing and mixing allergen vaccines for subcutaneous immunotherapy.
    Nelson HS
    Clin Allergy Immunol; 2008; 21():303-20. PubMed ID: 18828513
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy throughout the decades: from Noon to now.
    Finegold I; Dockhorn RJ; Ein D; Dolen WK; Oppenheimer J; Potter LH
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):328-36; quiz 337, 358. PubMed ID: 21055658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based dosing of maintenance subcutaneous immunotherapy: a contemporary review of state-of-the-art practice.
    Hoover H; Leatherman B; Ryan M; McMains K; Veling M
    Int Forum Allergy Rhinol; 2018 Jul; 8(7):806-816. PubMed ID: 29631326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous allergen specific immunotherapy: best clinical practice as cornerstone for future development.
    Senna GE; Makatsori M; Schiappoli M; Dama AR
    Eur Ann Allergy Clin Immunol; 2011 Oct; 43(5):135-40. PubMed ID: 22145249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
    Malling HJ
    Ugeskr Laeger; 1989 Nov; 151(48):3249-52. PubMed ID: 2595857
    [No Abstract]   [Full Text] [Related]  

  • 20. Sterilization and disinfection in the physician's office.
    Drummond DC; Skidmore AG
    CMAJ; 1991 Oct; 145(8):937-43. PubMed ID: 1913427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.